Please contact Customer Service with any questions. Ph: option 5

Size: px
Start display at page:

Download "Please contact Customer Service with any questions. Ph: option 5"

Transcription

1 Sarasota Memorial Laboratory Services is pleased to announce that we are now performing the following testing in house: Immature Platelet Fraction (IPF) The Immature Platelet Fraction (IPF) is used to monitor thrombopoiesis. The presence of immature platelets (also called Reticulated Platelets) helps to distinguish between bone marrow failure and peripheral platelet consumption or destruction. Provides a direct cellular measurement of thrombopoietic activity Supports determination of the cause/differential diagnosis of thrombocytopenia May help in determining need for prophylactic transfusions Direct measurement of immature platelet production for faster indication of response to therapy Recovery from chemotherapy and/or bone marrow transplant IPF is an indicator of platelet production by the bone marrow and is expressed as a percent of the total platelet count. RET (added with retic order) 0.5 ml of EDTA whole blood Lavender EDTA tube Daily Reference Range 1.1% to 6.1% CPT Code 85046

2 Anti-CCP Anti-CCP Test Cyclic Citrullinated Peptide (CCP) Used to detect antibodies to RA May be used in combination with clinical findings in the diagnosis of RA. Reference Range CCP 1 ml serum Gold top Tuesday and Thursday 5 U/mL = Negative >5 U/mL = Positive CPT Code 86200

3 The Reticulocyte Hemoglobin Equivalent (RET-HE) The Reticulocyte Hemoglobin Equivalent (RET-HE) quantifies the hemoglobin content of reticulocytes an aide in assessing iron available for erythropoiesis. Low hemoglobin content in reticulocytes indicates inadequate iron supply relative to demand. In patients with end-stage renal disease (ESRD) iron stores may not be adequate to sustain normal red cell production. RET-HE is useful for: A more comprehensive anemia work up, for early diagnosis of iron deficiency Monitoring iron status of patients with chronic kidney disease on hemodialysis, as well as for monitoring I.V. iron replacement and optimizing iron therapy Monitoring erythropoietin therapy To monitor athletes for use of EPO drugs The RET-HE is an indicator of the amount of hemoglobin in reticulocytes and is expressed as picograms. RET (added with retic order) 0.5 ml of EDTA whole blood Lavender EDTA tube Daily Reference Range pg CPT Code 85046

4 Immature Granulocyte Percent (IG%) Immature Granulocyte Percent (IG%) is a measurement of metamyelocytes, myelocytes and promyelocytes. (Bands and blasts are not included). Blasts will be reported separately. IG% will be a part of every CBC that is ordered. (No need to order) Anytime the IG% is greater than 5.0% manual review of a smear and/or a manual differential will be performed. with every CBC automatically 1 ml plasma Lavender EDTA tube Daily Reference Range 0-5% CPT Code 85025

5 Vitamin-D, 25-HYDROXY Low levels are associated with liver disorders, intestinal malabsorption, nephritic syndrome and calcium homeostasis as well as increased mortality including cardiovascular mortality, cancer incidence and mortality, Type 1 diabetes, hypertension, and autoimmune diseases such as multiple sclerosis. Special Instructions VITD25 Best practices related to the clinical lab testing efficacy demonstrate that PTH needs to be measured when 25-hydroxy Vitamin D is deficient. In addition, 1,25 Vit D is of diagnostic value only after elevated PTH has been measured. Physicians will be contacted prior to performing 1,25 Vit D if o The Lab has not received a prior order for Vitamin D, 25- hydroxy o The Vitamin-D, 25-hydroxy results are normal o The Lab has not received a prior order for a PTH o The PTH results are not elevated 1.0 ml serum Gold top Monday-Friday Reference Range Range Level ng/ml Deficient <10 Insufficient Sufficient Potential Intoxication >100 CPT Code 82306

6 The Epstein-Barr Virus Antibody Panel (EBV) The Epstein-Barr Virus Antibody Panel (EBV): consists of 4 components: VCA-IGG VCA-IGM EA-IGG EBNA Specimen Requirements Interpretation EBV 0.5 ml serum Gold top Monday, Wednesday and Friday The Epstein-Barr Virus Antibody Panel Interpretation: VCA- VCA- EA- EBNA IGG IGM IGG Susceptible Acute infection + + ± - Convalescent phase + ± ± + Chronic or reactivated ± Old infection ± CPT Code x 2, 86664, 86663

Evidence-Based Hematological Solutions

Evidence-Based Hematological Solutions Evidence-Based Hematological Solutions Beyond the Routine CBC Objectives Describe novel hematology parameters and their derivation. Investigate the evidence for their clinical utility. Discuss how new

More information

5/1/2017 DISCUSSION POINTS. Clinical Utility of Immature Cell Indices Beyond the Routine CBC John E. Donnelly BSN, RN

5/1/2017 DISCUSSION POINTS. Clinical Utility of Immature Cell Indices Beyond the Routine CBC John E. Donnelly BSN, RN DISCUSSION POINTS Importance of hematological immature cell indices Clinical Utility of Immature Cell Indices Beyond the Routine CBC John E. Donnelly BSN, RN Investigate the evidence for clinical utility:

More information

8/28/2015. ACP Toolbox SYSMEX CLINICAL SUPPORT TEAM SYSMEX CUSTOMER RESOURCE CENTER. Maggie Fischer BSN, RN, MS Carolyn Williams, BSN, RN, CRNI

8/28/2015. ACP Toolbox SYSMEX CLINICAL SUPPORT TEAM SYSMEX CUSTOMER RESOURCE CENTER. Maggie Fischer BSN, RN, MS Carolyn Williams, BSN, RN, CRNI ACP Toolbox Maggie Fischer BSN, RN, MS Carolyn Williams, BSN, RN, CRNI SYSMEX CLINICAL SUPPORT TEAM Available to provide education and resources: Tailored presentations Customer Resource Center tools Current

More information

of s and s Disclosure

of s and s Disclosure The s of s and s Successfully implement the Advanced Clinical Parameters to benefit the patient, the lab and the Accountable Care Organization Model Disclosure Honorarium from Sysmex for this lecture 1

More information

Nationwide Children s Hospital

Nationwide Children s Hospital Implementing IPF and RET He: Clinical Applications in a Pediatric Setting Gretchen Dennis MT(ASCP) cm, MLS(ASCP) Technical Specialist Routine Hematology Nationwide Children s Hospital 1 We have been growing!

More information

10/15/2015. Clinical Utility of Immature Cell Indices DISCUSSION POINTS HEALTHCARE REFORM PAYMENT MODEL EXPERIMENTS

10/15/2015. Clinical Utility of Immature Cell Indices DISCUSSION POINTS HEALTHCARE REFORM PAYMENT MODEL EXPERIMENTS Clinical Utility of Immature Cell Indices Leveraging Technology to Help Manage Anemia and Blood Utilization donnellyj@sysmex.com 2015 Sysmex America, Inc. All rights reserved. For Clinical Support Team

More information

It s Easier Than you Think How to Implement the Advanced Clinical Parameters

It s Easier Than you Think How to Implement the Advanced Clinical Parameters It s Easier Than you Think How to Implement the Advanced Clinical Parameters Implementation of our New Hematology Platform ( 9 HST Lines - 9 Facilities - 9 Month) Outline The Organization Banner Health

More information

Combining. and New Diagnostic. to Help Clinicians Achieve. Patient Outcomes at. per Healthcare Encounter

Combining. and New Diagnostic. to Help Clinicians Achieve. Patient Outcomes at. per Healthcare Encounter Combining and New Diagnostic to Help Clinicians Achieve Patient Outcomes at per Healthcare Encounter Holly McDaniel, MD hmcdaniel@clinpath.com Holly.mcdaniel@bannerhealth.com Holly McDaniel, MD AP/CP and

More information

LEANING Away Waste and Improving Patient Care with Advances in Hematology

LEANING Away Waste and Improving Patient Care with Advances in Hematology LEANING Away Waste and Improving Patient Care with Advances in Hematology Selke Mantie, MLS (ASCP), CLS (CSMLS), SSGBC Disclosure I am receiving an honorarium from Sysmex for today s presentation Objectives

More information

May is Better Sleep Month

May is Better Sleep Month Produced by Eastern Iowa Sleep Center A Partnership: UnityPoint-St.Luke s Mercy Medical Center Physicians Clinic of Iowa MAY 2015 VOLUME 4 ISSUE 2 Eastern Iowa Sleep Center May is Better Sleep Month Mother

More information

Advanced parameters offer faster, surer guidance to cancer care

Advanced parameters offer faster, surer guidance to cancer care Advanced parameters offer faster, surer guidance to cancer care captodayonline.com /advanced-parameters-offer-faster-surer-guidance-cancer-care/ Anne Paxton 9/18/2017 September 2017 After a career spent

More information

Notes for the 2 nd histology lab

Notes for the 2 nd histology lab Notes for the 2 nd histology lab Note : Please refer to the slides and see the morphological characteristics of each cell, as the practical exam will be in the form of figures. SLIDE #2 Erythropoiesis

More information

3/31/2017 OBJECTIVES CASE STUDY #1 MANUAL REVIEW. Hematology Case Studies: Every Picture Tells a Story

3/31/2017 OBJECTIVES CASE STUDY #1 MANUAL REVIEW. Hematology Case Studies: Every Picture Tells a Story OBJECTIVES Hematology Case Studies: Every Picture Tells a Story Jason Anderson, MPH, MT(ASCP) Field Product Specialist Discuss how scattergram and histogram pictures can provide insight into abnormal hematology

More information

Introduction to Haematology. Prof Roger Pool Department of Haematology University of Pretoria

Introduction to Haematology. Prof Roger Pool Department of Haematology University of Pretoria Introduction to Haematology Prof Roger Pool Department of Haematology University of Pretoria Suggested reading Haematology at a Glance Atul Mehta & Victor Hoffbrand Second Edition Published by Blackwell

More information

H. PYLORI AB, IGG HPYL

H. PYLORI AB, IGG HPYL H. PYLORI AB, IGG HPYL Specimen Required: 3 ml blood, Serum gel tube Analytical Time: 1 day CPT Code: 86677 HAPTOGLOBIN HAP Specimen Required: 1.5 ml blood, gel tube Reference Range: 30-200 mg/dl CPT Code:

More information

Full Blood Count analysis Is a 3 part-diff good enough? Dr Marion Münster, Sysmex South Africa

Full Blood Count analysis Is a 3 part-diff good enough? Dr Marion Münster, Sysmex South Africa Full Blood Count analysis Is a 3 part-diff good enough? Dr Marion Münster, Sysmex South Africa The Role of the FBC in clinical decision making History Examination Investigations Decision 70% FBC Laboratory

More information

Lavender Top Management SUCCESS BEYOND FINANCES

Lavender Top Management SUCCESS BEYOND FINANCES Lavender Top Management Alfonso Ziccardi Ass.Lab.Operation Manager for AP/CP/Safety Officer New York Hospital Medical Center of Queens SUCCESS BEYOND FINANCES 1 . VISION Mission/ Vision To successfully

More information

ANEMIA & HEMODIALYSIS

ANEMIA & HEMODIALYSIS ANEMIA & HEMODIALYSIS The anemia of CKD is, in most patients, normocytic and normochromic, and is due primarily to reduced production of erythropoietin by the kidney and to shortened red cell survival.

More information

Customer Information Literature List Platelets

Customer Information Literature List Platelets Customer Information Literature List Platelets Date: August 2015 Subject: Literature List Platelets Issued by: Scientific Customer Services Number: 150803 Note: Whether references are given in British

More information

HAEMATOLOGICAL MALIGNANCY

HAEMATOLOGICAL MALIGNANCY HAEMATOLOGICAL MALIGNANCY Reference Compulsory reading Haematology at Glance 2 nd ed. Atul Mehta & Victor Hoffbrand Chapters: 20 to 31 Pages: 46 to 69 Pathogenesis of Haematological Malignancy Figure (a)

More information

The importance of thrombocytopenia and its causes

The importance of thrombocytopenia and its causes SYSMEX EDUCATIONAL ENHANCEMENT AND DEVELOPMENT NO 4 2017 SEED HAEMATOLOGY The importance of thrombocytopenia and its causes Key words: Thrombocytopenia, thrombocytopenic, low levels of platelets What is

More information

Faculty of Medicine Dr. Tariq Aladily

Faculty of Medicine Dr. Tariq Aladily Iron deficiency anemia The most common anemia worldwide Only 10% of ingested iron is absorbed Most dietary iron occurs in meat products Absorbed in duodenum Hepcidin By inhibiting ferroportin, hepcidin

More information

Utilizing Sysmex RET He to Evaluate Anemia in Cancer Patients

Utilizing Sysmex RET He to Evaluate Anemia in Cancer Patients Utilizing Sysmex RET He to Evaluate Anemia in Cancer Patients Ellinor I. Peerschke, Ph.D., F.A.H.A. Vice Chair, Laboratory Medicine Chief, Hematology & Coagulation Laboratory Services Memorial Sloan Kettering

More information

The Complete Blood Count

The Complete Blood Count The Complete Blood Count (Cartesian Thinking at Its Best) A SEM Image of Normal Human Blood Laurie Larsson February 22, 2010 Anatomy and Philology II Dr. Danil Hammoudi Introduction A complete blood count

More information

Patient Information Specimen Information Client Information. Specimen: EN255254W. Requisition:

Patient Information Specimen Information Client Information. Specimen: EN255254W. Requisition: Patient Information Specimen Information Client Information MAIL000 Requisition: 0014895 DIRECT TO PATIENT- WEST HILLS Lab Ref #: PRO76199 8401 FALLBROOK AVE WEST HILLS, CA 91304-3226 Phone: 530.347.6380

More information

GOOD MORNING! Thursday, July Heidi Murphy, MD Leslie Carter-King, MD

GOOD MORNING! Thursday, July Heidi Murphy, MD Leslie Carter-King, MD GOOD MORNING! Thursday, July 10 2014 Heidi Murphy, MD Leslie Carter-King, MD PREP QUESTION Almost all infants experience a transient increase in bilirubin concentrations known as physiologic jaundice during

More information

Lavender Top Management SUCCESS BEYOND FINANCES. Mission/ Vision

Lavender Top Management SUCCESS BEYOND FINANCES. Mission/ Vision Lavender Top Management Alfonso Ziccardi Lab.Operation Manager for AP/CP/Safety Officer New York Hospital Medical Center of Queens SUCCESS BEYOND FINANCES Mission/ Vision. VISION To successfully develop

More information

Hematology: Challenging Cases with Your Participation COPYRIGHT

Hematology: Challenging Cases with Your Participation COPYRIGHT Hematology: Challenging Cases with Your Participation Reed E. Drews, MD Beth Israel Deaconess Medical Center Harvard Medical School Boston, MA Question 1 Question 1 64-year-old man is evaluated during

More information

Collect and label sample according to standard protocols. Gently invert tube 8-10 times immediately after draw. DO NOT SHAKE. Do not centrifuge.

Collect and label sample according to standard protocols. Gently invert tube 8-10 times immediately after draw. DO NOT SHAKE. Do not centrifuge. Complete Blood Count CPT Code: CBC with Differential: 85025 CBC without Differential: 85027 Order Code: CBC with Differential: C915 Includes: White blood cell, Red blood cell, Hematocrit, Hemoglobin, MCV,

More information

Interpath Laboratory, Inc. Test File Update

Interpath Laboratory, Inc. Test File Update As an Interpath customer who receives electronic results or sends electronic orders you may need to be notified when we update our Service Manual. Although we try to keep these changes to a minimum, laboratory

More information

Cbc with differential

Cbc with differential Cbc with differential Other tests might be necessary based on the results of the differential test and follow-up tests. Your doctor has many ways of determining and treating causes of abnormal blood cell

More information

Patient Information Specimen Information Client Information. Specimen: EN255254W. Requisition: TSENG, JUSTINA J DOB: 10/26/1955 AGE: 59

Patient Information Specimen Information Client Information. Specimen: EN255254W. Requisition: TSENG, JUSTINA J DOB: 10/26/1955 AGE: 59 Report Status: Final Patient Information Specimen Information Client Information Specimen: EN255254W Client #: 44123510 MAIL001 Requisition: 0014895 Lab Ref #: PRO76199 GREENVILLE RANCHERIA 1425 MONTGOMERY

More information

Applying clinical guidelines treating and managing CKD

Applying clinical guidelines treating and managing CKD Applying clinical guidelines treating and managing CKD Develop patient treatment plan according to level of severity. Source: Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012

More information

Form 2033 R3.0: Wiskott-Aldrich Syndrome Pre-HSCT Data

Form 2033 R3.0: Wiskott-Aldrich Syndrome Pre-HSCT Data Key Fields Sequence Number: Date Received: - - CIBMTR Center Number: CIBMTR Recipient ID: Has this patient's data been previously reported to USIDNET? USIDNET ID: Today's Date: - - Date of HSCT for which

More information

The Evolving Role of Reticulated Platelets

The Evolving Role of Reticulated Platelets The Evolving Role of Kyle Riding, PhD, MLS(ASCP) CM University of Central Florida Session Objectives Platelets Recall the process involved in megakaryopoiesis and thrombocytopoiesis Explain the various

More information

NEW HEMATOLOGY PARAMETERS

NEW HEMATOLOGY PARAMETERS NEW HEMATOLOGY PARAMETERS CASE STUDIES and IMPLEMENTATION WHAT WE WILL COVER new parameters Ret-He, IPF (and some not so new parameters) - anemias - hemoglobinopathies - problem platelets - uncommon things

More information

HEMATOLOGIC MORPHOLOGY- AECOM HEMATOLOGY COURSE

HEMATOLOGIC MORPHOLOGY- AECOM HEMATOLOGY COURSE Log Out Help current login :lcytryn@montefiore.org HEMATOLOGIC MORPHOLOGY- AECOM HEMATOLOGY COURSE Lawrence Cytryn, M.D. - Course Director 1998 Edward Burns, M.D. Images used by permission within AECOM

More information

Myelodysplasia/Myeloproliferative Neoplasms (MDS/MPN) Post-HCT Data

Myelodysplasia/Myeloproliferative Neoplasms (MDS/MPN) Post-HCT Data Instructions for Myelodysplasia/Myeloproliferative Neoplasms (MDS/MPN) Post-HCT Data (Form 2114) This section of the CIBMTR Forms Instruction Manual is intended to be a resource for completing the Myelodysplasia/Myeloproliferative

More information

HASNA NADIA BT. HASAN SAZALLI JOSEPHIN SUZANA A/K JOHN ASIN LOW NORZUFIKAL BT. ZULKIFLY NURUL ALIYA BT ROSLAN MOHD SYAFFIQ BIN OTHMAN

HASNA NADIA BT. HASAN SAZALLI JOSEPHIN SUZANA A/K JOHN ASIN LOW NORZUFIKAL BT. ZULKIFLY NURUL ALIYA BT ROSLAN MOHD SYAFFIQ BIN OTHMAN HASNA NADIA BT. HASAN SAZALLI JOSEPHIN SUZANA A/K JOHN ASIN LOW NORZUFIKAL BT. ZULKIFLY NURUL ALIYA BT ROSLAN MOHD SYAFFIQ BIN OTHMAN Anatomy of Bone Marrow Syaffiq Othman Bone Marrow Bone marrow is a

More information

Hematopoiesis Simplified: Part 1 Erythropoiesis

Hematopoiesis Simplified: Part 1 Erythropoiesis Hematopoiesis Simplified: Part 1 Erythropoiesis Larry Johnson Texas A&M University Hematopoiesis Simplified: Part 1 Erythropoiesis Objectives are to: Identify the developmental cells of erythropoiesis

More information

ALPS Screen Order Set B-Cell Panel Order Set (% and absolute #) (% and Absolute #) ALPS (CD3+/CD4-/CD8-/TCR αβ+)

ALPS Screen Order Set B-Cell Panel Order Set (% and absolute #) (% and Absolute #) ALPS (CD3+/CD4-/CD8-/TCR αβ+) All test indicated in a Panel or are available individually. Version 1/1/2018 ALPS Screen B-Cell Panel (% and absolute #) (% and Absolute #) ALPS (/CD4-/CD8-/TCR αβ+) CD5+/ ANA Profile * Anti-Nuclear Ab*

More information

Anemia. A case-based approach. David B. Sykes, MD, PhD Hematology, MGH Cancer Center June 8, 2017

Anemia. A case-based approach. David B. Sykes, MD, PhD Hematology, MGH Cancer Center June 8, 2017 Anemia A case-based approach David B. Sykes, MD, PhD Hematology, MGH Cancer Center June 8, 2017 Recognizing trends Learning Objectives MCV, RDW, Ferritin, LDH, Reticulocytes Managing complex patients 1.

More information

Clinician Blood Panel Results

Clinician Blood Panel Results Page 1 of 8 Blood Panel - Markers Out of Range and Patterns (Pattern: proprietary formula using one or more Blood Markers) Blood Panel: Check for Markers that are out of Lab Range ***NOTE*** Only one supplement

More information

Chapter 06 Lecture Outline. See separate PowerPoint slides for all figures and tables preinserted into PowerPoint without notes.

Chapter 06 Lecture Outline. See separate PowerPoint slides for all figures and tables preinserted into PowerPoint without notes. Chapter 06 Lecture Outline See separate PowerPoint slides for all figures and tables preinserted into PowerPoint without notes. Copyright 2016 McGraw-Hill Education. 2012 Pearson Permission Education,

More information

Blood DLC, Retic count, PCV, Hb and ESR. Dr. Tamara Alqudah

Blood DLC, Retic count, PCV, Hb and ESR. Dr. Tamara Alqudah Blood DLC, Retic count, PCV, Hb and ESR Dr. Tamara Alqudah Differential Leukocyte Count (DLC) There are 5 main types of WBCs: 1. Neutrophils: 40-80% 2. Eosinophils: 1-6 % 3. Basophils: < 1-2% 4. Lymphocytes:

More information

Specific Panels. Celiac disease panel. Pancreas Panel:

Specific Panels. Celiac disease panel. Pancreas Panel: Specific Panels Celiac disease panel Anti Endomysium IgA Anti Endomysium IgG Anti Gliadin IgA Anti Gliadin IgG Anti Transglutaminase IgA Anti Transglutaminase IgG Total IgA Total IgG Stool analysis +Sudan

More information

Introduction and II. Blood Cells A. Introduction

Introduction and II. Blood Cells A. Introduction Chapter 14: Blood 1. Blood is three to four times more viscous than water. Introduction and II. Blood Cells A. Introduction 2. Most blood cells form in red bone marrow. 3. Types of blood cells are red

More information

Abbott Cell-Dyn Reticulocyte Method Comparison and Reticulocyte Normal Reference Range Evaluation

Abbott Cell-Dyn Reticulocyte Method Comparison and Reticulocyte Normal Reference Range Evaluation Laboratory Hematology 8:85-90 2002 Carden Jennings Publishing Co.. Ltd. Abbott Cell-Dyn Reticulocyte Method Comparison and Reticulocyte Normal Reference Range Evaluation T. SCHISANO, L. VAN HOVE Abbott

More information

PATHOLOGY & PATHOPHYSIOLOGY

PATHOLOGY & PATHOPHYSIOLOGY PATHOLOGY & PATHOPHYSIOLOGY DISORDERS OF BLOOD DISORDERS OF BLOOD Disorders of Blood Infections Tumours Nutritional disorders Coagulation disorders Congenital disorders Septicaemia Leukemia Iron deficiency

More information

XN series. Case interpretation. Gebruikersdag Vlaanderen- 6 oktober 2016

XN series. Case interpretation. Gebruikersdag Vlaanderen- 6 oktober 2016 XN series Case interpretation Gebruikersdag Vlaanderen- 6 oktober 2016 Fluorescence flow cytometry RET channel PLT-F channel WDF channel WPC channel WNR channel Case 1 Case 1: Initial measurement Patient

More information

APPROACHING TO PANCYTOPENIA

APPROACHING TO PANCYTOPENIA APPROACHING TO PANCYTOPENIA P A T C H A R E E K O M V I L A I S A K, M. D. A S S I S T A N T P R O F E S S O R D I V I S I O N O F P E D I A T R I C H E M A T O L O G Y O N C O L O G Y, D E P A R T M E

More information

Known as EPO MW 30400Da Discovered by Miyake et al 1977from urine of anaemic pts. LC 4 alpha helical bundle class 1 cytokine

Known as EPO MW 30400Da Discovered by Miyake et al 1977from urine of anaemic pts. LC 4 alpha helical bundle class 1 cytokine Erythropoietin Known as EPO MW 30400Da Discovered by Miyake et al 1977from urine of anaemic pts. LC 4 alpha helical bundle class 1 cytokine 193 a.a. human (192 mouse) When levels low e.g.in CRF, chemotherapy

More information

Drugs Used in Anemia

Drugs Used in Anemia Drugs Used in Anemia Drugs of Anemia Anemia is defined as a below-normal plasma hemoglobin concentration resulting from: a decreased number of circulating red blood cells or an abnormally low total hemoglobin

More information

The Diabetes Kidney Disease Connection Missouri Foundation for Health February 26, 2009

The Diabetes Kidney Disease Connection Missouri Foundation for Health February 26, 2009 The Diabetes Kidney Disease Connection Missouri Foundation for Health February 26, 2009 Teresa Northcutt, RN BSN Primaris Program Manager, Prevention - CKD MO-09-01-CKD This material was prepared by Primaris,

More information

Do Now pg What part of the blood causes a blood clot? 2. Could you survive without this? Why?

Do Now pg What part of the blood causes a blood clot? 2. Could you survive without this? Why? Do Now pg 95 1. What part of the blood causes a blood clot? 2. Could you survive without this? Why? What is Hemostasis? The stopping of bleeding, which is vitally important when blood vessels are damaged.

More information

Blutbild 2012: Automatisiert oder manuell? Georg Stüssi Servizio di Ematologia Istituto Oncologico della Svizzera Italiana

Blutbild 2012: Automatisiert oder manuell? Georg Stüssi Servizio di Ematologia Istituto Oncologico della Svizzera Italiana Blutbild 2012: Automatisiert oder manuell? Georg Stüssi Servizio di Ematologia Istituto Oncologico della Svizzera Italiana IS THERE STILL A ROLE FOR THE MANUAL BLOOD COUNT? Indication for examination

More information

General Characterisctics

General Characterisctics Anemia General Characterisctics Definition: anemia is a decrease in red blood cells. Happens due to underproduction, increased destruction or loss of red cells. Diagnosis of anemia: Hgb < 135 (men) Hgb

More information

Alkaline Phosphatase, Bone Specific

Alkaline Phosphatase, Bone Specific Alkaline Phosphatase, Bone Specific Order Name: ALK P BONE Test Number: 3656500 REV DATE:11/5/2010 Alkaline Phosphatase, Bone Specific IMMENZ Preferred 1 ml (0.3) Serum Clot Activator SST (Red/Gray or

More information

I. Definitions. V. Evaluation A. History B. Physical Exam C. Laboratory evaluation D. Bone marrow examination E. Specialty referrals

I. Definitions. V. Evaluation A. History B. Physical Exam C. Laboratory evaluation D. Bone marrow examination E. Specialty referrals I. Definitions II. III. Red blood cell life cycle Iron metabolism IV. Causes of anemia A. Kinetic approach 1. decreased production 2. increased destruction 3. blood loss B. Morphologic approach 1. normocytic

More information

* imagine if the Hb is free ( e.g. hemolysis ) in the plasma what happens?

* imagine if the Hb is free ( e.g. hemolysis ) in the plasma what happens? In this lecture we will talk about Some characteristics of RBC. Erythrpoiesis : * During fetal & adult life. * its regulation. RBCs : - Appear under the microscope as circular,unnucleated and biconcave

More information

ADx Bone Marrow Report. Patient Information Referring Physician Specimen Information

ADx Bone Marrow Report. Patient Information Referring Physician Specimen Information ADx Bone Marrow Report Patient Information Referring Physician Specimen Information Patient Name: Specimen: Bone Marrow Site: Left iliac Physician: Accession #: ID#: Reported: 08/19/2014 - CHRONIC MYELOGENOUS

More information

Rory McCulloch. Specialty Trainee Haematology Royal Devon & Exeter Hospital

Rory McCulloch. Specialty Trainee Haematology Royal Devon & Exeter Hospital Rory McCulloch Specialty Trainee Haematology Royal Devon & Exeter Hospital Anaemia 1 Haematological disorders Anaemia 2 Non-haematological disorders Substrates: Iron, folate, vitamin B12 Red cell mass

More information

Hematology Revision. By Dr.AboRashad . Mob

Hematology Revision. By Dr.AboRashad  . Mob 1 1- Hb A2 is consisting of: a) 3 ά chains and 2 γ chains b) 2 ά chains and 2 β chains c) 2 ά chains and 2 δ chains** d) 2 ά chains and 3 δ chains e) 3 ά chains and 2 δ chains 2- The main (most) Hb found

More information

Platelet and WBC disorders

Platelet and WBC disorders Division of Family Practice Platelet and WBC disorders Adrian Yee MD FRCPC Clinical hematologist Assistant Dean, undergraduate education, IMP asyee@uvic.ca When we understand that slide, we'll have won

More information

REFERENCE LABORATORY. Regular Hours - Monday through Friday 8:00 AM to 4:00 PM. On-Call Staff - Evenings, Nights, Weekend and Holidays.

REFERENCE LABORATORY. Regular Hours - Monday through Friday 8:00 AM to 4:00 PM. On-Call Staff - Evenings, Nights, Weekend and Holidays. I. REFERENCE LABORATORY HOURS OF OPERATION: Regular Hours - Monday through Friday 8:00 AM to 4:00 PM. On-Call Staff - Evenings, Nights, Weekend and Holidays. All Reference Lab procedures are subject to

More information

Basic Metabolic Panel

Basic Metabolic Panel Basic Metabolic Panel Order Name: CHEM 8 Test Number: 2028100 REV DATE:2/5/2008 Glucose Urea Nitrogen, Blood (BUN) Creatinine Sodium Potassium Serum/Plasma Chloride Bicarbonate Calcium Anion Gap Calculated

More information

XN-SERIES. XN Technology and Case Studies

XN-SERIES. XN Technology and Case Studies XN Technology and Case Studies Karen Hoffman MT(ASCP) Clinical Applications Specialist OBJECTIVES Explain how scattergrams and histogram pictures can provide great insight into abnormal hematology samples

More information

Hematopoietic Growth Factors Colony Stimulating Factors. Erythropoietin (Epoetin alfa). Granulocyte-macrophage colonystimulating factor (G-CSF).

Hematopoietic Growth Factors Colony Stimulating Factors. Erythropoietin (Epoetin alfa). Granulocyte-macrophage colonystimulating factor (G-CSF). Hematopoietic Growth Factors Colony Stimulating Factors. Erythropoietin (Epoetin alfa). Granulocyte colony-stimulating factor(g-csf). Granulocyte-macrophage colonystimulating factor (G-CSF). Interleukin-11

More information

XN-SERIES. Hematology Case Studies: Every Picture Tells a Story

XN-SERIES. Hematology Case Studies: Every Picture Tells a Story Hematology Case Studies: Every Picture Tells a Story Jill Crist MT(ASCP)Field Product Specialist OBJECTIVES Explain how scattergrams and histogram pictures can provide great insight into abnormal hematology

More information

The Power of Peripheral Blood Smears: Apparent Diagnostic Clues (Part 1) (Wednesday, October 19, 2011)

The Power of Peripheral Blood Smears: Apparent Diagnostic Clues (Part 1) (Wednesday, October 19, 2011) The Power of Peripheral Blood Smears: Apparent Diagnostic Clues (Part 1) (Wednesday, October 19, 2011) By Gene Gulati, Ph.D., SH(ASCP) Conflict of Interest None Plan for the Course Review blood smears,

More information

CASE STUDIES PERIPHERAL BLOOD AND BODY FLUIDS

CASE STUDIES PERIPHERAL BLOOD AND BODY FLUIDS CASE STUDIES PERIPHERAL BLOOD AND BODY FLUIDS WHERE TO START anemias hemoglobinopathies new and old parameters uncommon things fluids.benign and malignant.yuk! really annoying stuff and maybe some entertainment

More information

27027 Tourney Road Valencia, CA 91355 800 421 7110 www.specialtylabs.com Test Updates November 26, 2008 Dear Colleague: We are pleased to announce the availability of two new assays for an expanded evaluation

More information

Continuing Education Questions

Continuing Education Questions FOCUS: INTERPRETING THE COMPLETE BLOOD COUNT Continuing Education Questions SUMMER 2017 1. A methodical approach to CBC interpretation that is aimed at medical laboratory professionals differs from one

More information

Chapter 28. Media Directory. Hematopoiesis. Regulation of Hematopoiesis. Erythropoietin. Drugs for Hematopoietic Disorders

Chapter 28. Media Directory. Hematopoiesis. Regulation of Hematopoiesis. Erythropoietin. Drugs for Hematopoietic Disorders Chapter 28 Drugs for Hematopoietic Disorders Slide 35 Media Directory Epoetin Alfa Animation Upper Saddle River, New Jersey 07458 All rights reserved. Hematopoiesis Figure 28.1 Hematopoiesis Process of

More information

INFLUENCE OF LOW PROTEIN DIET IN IMPROVING ANEMIA TREATED WITH ERYTHROPOETIN

INFLUENCE OF LOW PROTEIN DIET IN IMPROVING ANEMIA TREATED WITH ERYTHROPOETIN INFLUENCE OF LOW PROTEIN DIET IN IMPROVING ANEMIA TREATED WITH ERYTHROPOETIN, Idrizi A, Barbullushi M, Gjyzari A, Duraku A Department of Nephrology, University Hospital Center, Tirana, Albania Introduction

More information

To be used for the ease of test requisitioning on select patients only; all components may be ordered separately

To be used for the ease of test requisitioning on select patients only; all components may be ordered separately Panels Section To be used for the ease of test requisitioning on select patients only; all components may be ordered separately ANEMIA 1(I) PANEL (NMC & UMMC) ANEM1(I) S 8.0 ml Large Tests included are:

More information

Interpath Laboratory, Inc. Test File Update

Interpath Laboratory, Inc. Test File Update As an Interpath customer who receives electronic results or sends electronic orders you may need to be notified when we update our Service Manual. Although we try to keep these changes to a minimum, laboratory

More information

Updates in the Management of Anemia in Cancer. Taylor M. Ortiz, MD May 19, 2017

Updates in the Management of Anemia in Cancer. Taylor M. Ortiz, MD May 19, 2017 Updates in the Management of Anemia in Cancer Taylor M. Ortiz, MD May 19, 2017 Objectives Recall common causes of anemia in patients with cancer Understand risks/benefits of blood transfusion in patients

More information

Taking The Fear Out of Abnormal CBC s Problems of Production, Destruction or loss

Taking The Fear Out of Abnormal CBC s Problems of Production, Destruction or loss Taking The Fear Out of Abnormal CBC s Problems of Production, Destruction or loss Joanne Eddington, MN, FNP, AOCN Providence Oncology and Hematology Care Clinic - Eastside Blood Cell Abnormalities Abnormalities

More information

Management of anemia in CKD

Management of anemia in CKD Management of anemia in CKD Pierre Cochat, MD PhD Professor of Pediatrics Chair, Pediatrics & Pediatric Surgery Department Head, Center for Rare Renal Diseases Néphrogones Hospices Civils de Lyon & University

More information

Clinician Blood Panel Results

Clinician Blood Panel Results Page 1 of 7 Blood Panel - Markers Out of Range and Patterns (Pattern: proprietary formula using one or more Blood Markers) Blood Panel: Check for Markers that are out of Lab Range ***NOTE*** Only one supplement

More information

PNH Glossary of Terms

PNH Glossary of Terms AA Absolute neutrophil count Alendronate Allergen ALT Anemia Antibodies Anticoagulant Anticoagulation Antigen Antithymocyte globulin (ATG) Aplastic Aplastic anemia Band Bilirubin Blast cells Bone marrow

More information

9/23/2018. Hematology Case Studies Jason Anderson, MPH, MT(ASCP) Field Product Specialist OBJECTIVES FLUORESCENT FLOW CYTOMETRY

9/23/2018. Hematology Case Studies Jason Anderson, MPH, MT(ASCP) Field Product Specialist OBJECTIVES FLUORESCENT FLOW CYTOMETRY Hematology Case Studies Jason Anderson, MPH, MT(ASCP) Field Product Specialist OBJECTIVES Discuss how scattergram and histogram pictures can provide insight into abnormal hematology samples Utilize case

More information

27027 Tourney Road Valencia, CA 91355 800 421 7110 www.specialtylabs.com Test Updates July 27, 2009 Dear Colleague: As we prepare for the upcoming flu season, Specialty Laboratories clients should be aware

More information

Summary of Recommendation Statements Kidney International Supplements (2012) 2, ; doi: /kisup

Summary of Recommendation Statements Kidney International Supplements (2012) 2, ; doi: /kisup http://www.kidney-international.org & 2012 KDIGO Summary of Recommendation Statements Kidney International Supplements (2012) 2, 283 287; doi:10.1038/kisup.2012.41 Chapter 1: Diagnosis and evaluation of

More information

HEAMATOLOGICAL INDICES AND BONE MARROW BIOPSY

HEAMATOLOGICAL INDICES AND BONE MARROW BIOPSY HEAMATOLOGICAL INDICES AND BONE MARROW BIOPSY HEMATOCRIT Hematocrit is a measure of the percentage of the total blood volume that is made up by the red blood cells The hematocrit can be determined directly

More information

CPT Code: Serum Urea Nitrogen, Urine Urea Nitrogen in mg/dl, 24 hour Urine Urea Nitrogen, Urea Clearance

CPT Code: Serum Urea Nitrogen, Urine Urea Nitrogen in mg/dl, 24 hour Urine Urea Nitrogen, Urea Clearance UREA CLEARANCE UREACL Specimen Required: 2.5 ml blood, gel tube and total collection 24 hour urine Special Instructions: Refrigerate urine during collection. Provide starting date and time, and ending

More information

TEST LIST SAMPLE REQUIREMENT. 1 ml serum None

TEST LIST SAMPLE REQUIREMENT. 1 ml serum None ALBUMIN TEST NAME ALKALINE PHOSPHATASE ALLERGY PROFILE, FOOD 30 allergens ALLERGY PROFILE, INHALANT 30 Allergens ALT AMYLASE ANA ANTI- TG ANTI-GLIADIN IGG ANTI-GLIADIN IGA ANTI-HBS ANTI-HCV ANTI-TPO APOLIPOPROTEIN

More information

Myelodysplastic Syndrome: Let s build a definition

Myelodysplastic Syndrome: Let s build a definition 1 MDS: Diagnosis and Treatment Update Gail J. Roboz, M.D. Director, Leukemia Program Associate Professor of Medicine Weill Medical College of Cornell University The New York Presbyterian Hospital Myelodysplastic

More information

Rapid Laboratories In House Tests

Rapid Laboratories In House Tests Electrolytes CL CL (CHLORIDE) Electrolytes CO2 CO2 (BICARBONATE) Electrolytes K K (POTASSIUM) Electrolytes NA NA (SODIUM) Basic Metabolic Panel (BMP) GLU GLU (GLUCOSE) Basic Metabolic Panel (BMP) CA CA

More information

TSAT PROJECT Shean Strong, QI Director Lisle Mukai, QI Coordinator

TSAT PROJECT Shean Strong, QI Director Lisle Mukai, QI Coordinator Southern California Renal Disease Council, Inc. ESRD Network 18 TSAT PROJECT Shean Strong, QI Director Lisle Mukai, QI Coordinator TSAT 6255 West Sunset blvd Los Angeles, California i 90028 11/24/2010

More information

Test Bulletin. Save time, money, resources, and precious blood by NOT collecting extra specimens just in case

Test Bulletin. Save time, money, resources, and precious blood by NOT collecting extra specimens just in case Test Bulletin October 2018 Save time, money, resources, and precious blood by NOT collecting extra specimens just in case ACL Laboratories has seen an increase in the number of specimens submitted without

More information

FOCUS ON IRON-DEFICIENCY ANEMIA AND ITS TREATMENT

FOCUS ON IRON-DEFICIENCY ANEMIA AND ITS TREATMENT FOCUS ON IRON-DEFICIENCY ANEMIA AND ITS TREATMENT What you need to know 8846 In Vivo Takeda Feraheme Flip Chart-v3.indd 1 13-01-16 9:37 AM BLOOD AND ITS IMPORTANCE IN YOUR BODY Blood circulates throughout

More information

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Intermediate Outcome

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Intermediate Outcome Quality ID #328 (NQF 1667): Pediatric Kidney Disease: ESRD Patients Receiving Dialysis: Hemoglobin Level < 10 g/dl National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL

More information

Hematology 101. Cindy Rogers, MT(ASCP) Diagnostics System Specialist

Hematology 101. Cindy Rogers, MT(ASCP) Diagnostics System Specialist Hematology 101 Cindy Rogers, MT(ASCP) Diagnostics System Specialist More Acronyms...» CBC» RBC» HGB» HCT» WBC» MPV» PLT» RDW» DIFF» H&H» Complete Blood Count» Red Blood Cell» Hemoglobin» Hematocrit» White

More information

Essentials of Human Anatomy and Physiology, 11e (Marieb) Chapter 10 Blood Multiple Choice Part I Questions

Essentials of Human Anatomy and Physiology, 11e (Marieb) Chapter 10 Blood Multiple Choice Part I Questions Essentials of Human Anatomy and Physiology, 11e (Marieb) Chapter 10 Blood 10.1 Multiple Choice Part I Questions Using Figure 10.1, identify the following: 1) The neutrophil is indicated by. A) Label A

More information

Other labs 4/24/2012. N 24: Pediatric Hematological Alterations & Cancer Intro. Cabrillo College ADN Program C. Madsen RN, MSN 1.

Other labs 4/24/2012. N 24: Pediatric Hematological Alterations & Cancer Intro. Cabrillo College ADN Program C. Madsen RN, MSN 1. Evaluation of CBC Evaluate type of WBCs Reticulocyte count RBC size, shape, color MCV: size RBC color (hypo or normo chromic) Mean corpuscular hemoglobin concentration (MCHC) Mean corpuscular hemoglobin

More information

Disease Pathogenesis and Research Progression of Renal Anemia

Disease Pathogenesis and Research Progression of Renal Anemia 2018 3rd International Conference on Life Sciences, Medicine, and Health (ICLSMH 2018) Disease Pathogenesis and Research Progression of Renal Anemia Yingying Liu, Qi Jiang* Department of Nephrology, China-Japan

More information

Hematology Unit Lab 1 Review Material

Hematology Unit Lab 1 Review Material Hematology Unit Lab 1 Review Material - 2018 Objectives Laboratory instructors: 1. Assist students during lab session Students: 1. Review the introductory material 2. Study the case histories provided

More information

Effective Health Care Program

Effective Health Care Program Comparative Effectiveness Review Number 83 Effective Health Care Program Biomarkers for Assessing and Managing Iron Deficiency Anemia in Late-Stage Chronic Kidney Disease Executive Summary Background Chronic

More information